SYNTHESIS OF (4AS,7AS)-OCTAHYDRO-1H-PYRROLO[3,4-B]PYRIDINE

The present invention relates to the stereoselective synthesis of (4aS,7aS)-octahydro-1H-pyrrolo [3, 4-b]pyridine, as well as the conversion thereof, to give Moxifloxacin. Particularly, the present invention relates to a method for the synthesis of (4aS,7aS)-octahydro-1H-pyrrolo [3, 4-b]pyridine of...

Full description

Saved in:
Bibliographic Details
Main Authors ARVOTTI, GIANCARLO, BERGANTINO, ELISABETTA, MOTTERLE, RICCARDO, FOGAL, STEFANO, GALVAGNI, MARCO, CASTELLIN, ANDREA
Format Patent
LanguageEnglish
French
Published 11.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the stereoselective synthesis of (4aS,7aS)-octahydro-1H-pyrrolo [3, 4-b]pyridine, as well as the conversion thereof, to give Moxifloxacin. Particularly, the present invention relates to a method for the synthesis of (4aS,7aS)-octahydro-1H-pyrrolo [3, 4-b]pyridine of formula (I) comprising : (a) the optical resolution by enzymatic hydrolysis of the intermediate dialkyl-1-alkylcarbonylpiperidine-2,3-dicarboxylate racemate of formula (II) to give, following isolation, the intermediate dialkyl-(2S,3R)-1-alkylcarbonyl-piperidine-2,3-dicarboxylate of formula (III) in which Alk is a straight or branched C1-C5 alkyl group; (b) the conversion of the intermediate (III) to (4aR,7aS)-1-alkylcarbonylhexahydrofuro [3, 4-b]pyridine-5,7-dione of formula (IV) in which Alk has the meanings set forth above; (c) the conversion of the intermediate (IV) to (4aS,7as)-octahydro-1H-pyrrolo[3, 4-b]pyridine of formula (I) with an optical purity above 99%. L'invention concerne la synthèse stéréosélective de (4aS, 7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine, ainsi que sa conversion, pour donner la moxifloxacine. En particulier, la présente invention porte sur un procédé de synthèse de la (4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridine de formule (I) comprenant : (a) la résolution optique par hydrolyse enzymatique de l'intermédiaire dialkyl-1-alkylcarbonylpipéridine-2,3-dicarboxylate racémate de formule (II) pour donner, après isolement, l'intermédiaire dialkyl-(2S,3R)-1-alkylcarbonyl-pipéridine-2,3-dicarboxylate de formule (III) dans lequel Alk est un groupe alkyle en C1-C5 à chaîne droite ou ramifiée; (b) la conversion de l'intermédiaire (III) en la (4aR,7aS)-1-alkylcarbonylhexahydrofuro[3,4-b]pyridine-5,7-dione de formule (IV) dans laquelle Alk a les significations énoncées ci-dessus; (c) la conversion de l'intermédiaire (IV) en la (4aS,7as)-octahydro-1H-pyrrolo[3,4-b]pyridine de formule (I) avec une pureté optique au-dessus de 99 %.
Bibliography:Application Number: CA20102751548